Addex Therapeutics's total assets for Q1 2025 were CHF9.48M, a decrease of -11.18% from the previous quarter. ADXN total liabilities were CHF1.19M for the fiscal quarter, a 18.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.